newsfilter
← Latest News
GlobeNewswire·

Revolution Medicines to Present at 44th Annual J.P. Morgan Healthcare Conference

REDWOOD CITY, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (NASDAQ:RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today